Two polyhydroxyfullerenes, which decrease organophosphate (OP)-induced acetylcholinesterase (AChE) inhibition in vitro, were administered by the intraperitoneal (ip) route or applied topically at doses of 0.9-24 mg/kg to protect adult male mice from enzyme-inhibiting and behavioral effects indicative of OP toxicity resulting from exposure to 1.7 - 2 mg/kg diphosphorofluoridate (DFP) ip or 2.3 - 2.7 mg paraoxon topical. Dosing paradigms included OP-fullerene simultaneous administration by the ip route, and 20 min post-OP polyhydroxyfullerene treatment topically. Benefits of OP sequestration by the polyhydroxyfullerene were noted and were dependent on the OP compound as well as timing and route of the polyhydroxyfullerene treatment.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608077PMC
http://dx.doi.org/10.1016/j.tox.2020.152586DOI Listing

Publication Analysis

Top Keywords

polyhydroxyfullerene treatment
8
effects polyhydroxyfullerenes
4
polyhydroxyfullerenes organophosphate-induced
4
organophosphate-induced toxicity
4
toxicity mice
4
mice polyhydroxyfullerenes
4
polyhydroxyfullerenes decrease
4
decrease organophosphate
4
organophosphate op-induced
4
op-induced acetylcholinesterase
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!